Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
11/2010
11/09/2010US7829725 Triazolium cation and fluoroalkylsulfonate or fluoroalkylsulfonylimide anions; solvents, catalysts
11/09/2010US7829724 N-(1-(5-(2-(1H-indol-3-yl)ethyl)-4-(2,4-dimethoxybenzyl)-4H-1,2,4-triazol-3-yl)-2-(1H-indol-3-yl)ethyl)-2-amino-2-methylpropanamide; useful for treating growth retardation, cachexia, obesity, food intake, energy balance, tumor cell proliferation, wound/burn healing, metabolic disorders and inflammation.
11/09/2010US7829705 such as 7-{2-[1-(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-4-ethoxy-cinnoline, used in the treatment of picornavirus infections in humans
11/09/2010US7829639 Composition for conductive layers in electronic devices
11/09/2010US7829589 growth hormone secretagogue receptor modulators such as (R)-3-(diethylamino)-N-(1-(3-(4-fluorophenyl)-1H-1,2,4-triazol-5-yl)-3-phenylpropyl)propane-1-sulfonamide, used for the treatment of diabetes, obesity, cardiovascular disease, stroke and as anticarcinogenic or antitumor agents
11/09/2010US7829588 Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
11/09/2010CA2484188C Tachykinin receptor antagonists
11/04/2010WO2010127088A2 Intramolecular azide-alkyne cycloaddition
11/04/2010US20100280256 Process for preparing triazolones
11/04/2010US20100278732 1h-[1, 2, 3] triazole substituted amino acids and uses thereof
11/03/2010EP1496838B1 Substituted amides
11/03/2010CN101875652A Triazole derivative, and light-emitting element, light-emitting device, lighting device, and electronic device using triazole derivative
11/02/2010US7825278 Central nervous system disorders; gamma aminobutyric acid (GABA) receptor complex modulators
11/02/2010US7825257 2-[3'-t-butyl-2'-hydroxy-5'-(3''-methacryloxypropyl)phenyl]-5-chlorobenzotriazole; use of benzotriazole monomers with one or more other monomers to prepare ultraviolet light absorbing polymer compositions for ocular devices, particularly intraocular lenses and contact lenses
11/02/2010US7825148 heat shock protein 90 inhibitors such as 3-(2-Hydroxyphenyl)-4-(naphthalen-1-yl)-5-mercapto-triazole, used for for preventing or treating hyperproliferative disorders, such as cancer
11/02/2010US7825142 imidazole-based compounds such as (1R,2S,3R)-1-(2-(5-methylisoxazol-3-yl)-1H-imidazol-5-yl)butane-1,2,3,4-tetraol, used for the treatment and prevention of inflammatory and autoimmune diseases
11/02/2010CA2400167C Insecticidal anthranilamides
10/2010
10/28/2010WO2010122170A1 5-mercapto- [1,2,4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceuti al uses
10/28/2010WO2010122169A1 5-mercapto- [1,2, 4] triazole compounds and their agricultural and pharmaceutical uses
10/28/2010WO2010122167A1 5 -mercapto- [1, 2, 4] triazolylmethyl-cyclopentanol compounds and their agricultural and pharmaceutical uses
10/28/2010WO2010122088A1 Pyrazole and triazole carboxamides as crac channel inhibitors
10/28/2010US20100273824 Substituted 1,3-dioxanes and their uses
10/28/2010US20100273801 Betulin derived compounds useful as antibacterial agents
10/28/2010US20100273739 Aminotetraline Derivatives, Pharmaceutical Composition, Containing Them, and Their Use in Therapy
10/28/2010US20100273651 Azolylmethyloxiranes, use Thereof and Agents Containing the Same
10/27/2010EP2242739A1 Insecticidal arylpyrrolines
10/27/2010CN1819996B Naphthylene derivatives as cytochrome P450 inhibitors
10/26/2010US7820825 N-substituted-azacyclylamines as histamine-3 antagonists
10/26/2010US7820347 dehalogenation with dinitrogen tetroxide to form a triazolium nitrate; without the need for silver salts therewith and reduced costs; intermediate for pharmaceutical and agricultural agents; highly energetic compounds for explosives, propellants and gas-generating
10/21/2010WO2010120852A1 Cyclic energetic nitramines desensitized with linear nitramines
10/21/2010US20100267725 Compounds, Compositions and Methods Comprising 4N-Substituted Triazole Derivatives
10/21/2010US20100267724 S-triazole alpha-mercaptoacetanilides as inhibitors of hiv reverse transcriptase
10/21/2010US20100267714 Mif modulators
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/20/2010EP2240019A1 Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
10/20/2010EP1811998B1 Triazoles useful as inhibitors of protein kinases
10/20/2010CN101863875A Triazole derivatives containing liquid crystal units and preparation method and application thereof
10/20/2010CN101863847A Preparation method of sulfonanilide compound
10/19/2010US7816538 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases
10/19/2010US7816537 Process for the manufacture of epoxybutanol intermediates
10/19/2010US7816534 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/19/2010US7816527 Quinazoline-containing kits for labeling aldehyde or ketone moieties
10/19/2010US7816522 Triazolone derivatives
10/19/2010US7816398 Fatty alcohol drug conjugates
10/19/2010US7816387 β secretase inhibitor
10/19/2010US7816365 Amine derivatives
10/19/2010US7816363 Inhibitors of histone deacetylase
10/19/2010US7816360 MTP inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles
10/19/2010US7816350 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout
10/14/2010WO2010117040A1 Five-membered heterocyclic compound
10/14/2010WO2010115881A1 Imaging the central nervous system with purinergic p2x7 receptor binding agents
10/14/2010US20100261930 Tricyclic-Bis-Enone Derivatives and Methods of Use Thereof
10/14/2010US20100261771 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
10/13/2010EP1861465B1 Chromophore coated metal oxide particles
10/13/2010CN101861363A Azo compound, and dye-containing polarizing film comprising the same
10/13/2010CN101857576A Simple method for preparing cyproconazole by cyclopropyl methyl ketone
10/12/2010US7812045 1-(5-(4-trifluoromethyl-benzylamino)-1H-indazol-1-yl)-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol; 2-(2,4-difluorophenyl)-1-(1H-indazol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol
10/07/2010WO2010113151A1 Conjugated antimicrobial agents
10/07/2010WO2010112116A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010US20100256387 Diaryltriazoles as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/07/2010US20100256386 Aryl (1h-1,2,4-triazol-1-yl) compound and process for production thereof
10/07/2010US20100256357 Heterocycles useful as inhibitors of carbonic anhydrase
10/07/2010US20100256115 Inhibitors of iap
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/06/2010EP2236499A1 Heterocyclic compound, and light-emitting element, light-emitting device, lighting device, and electronic appliance using heterocyclic compound
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010CN101855206A N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides
10/06/2010CN101851230A Heterocyclic compound, and light-emitting element, light-emitting device, lighting device, and electronic appliance using heterocyclic compound
10/05/2010US7807701 Dibenzylamine compounds and pharmaceutical use thereof
10/05/2010US7807698 Such as (1S,5R)-3-{3-[(5-cyclopropyl-4-methyl-4H-1,2,4-triazol-3-yl)thio]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; for use as modulators of dopamine D3 receptors, antipsychotic agents, treatment of obsessive compulsive spectrum disorders and/or premature ejaculation
10/05/2010US7807690 such as 2-(3-aminopyridin-2-yl)-5-[(1-imino-2,3-dihydro-1H-isoindol-5-ylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-2,4-dihydro-1,2,4-triazol-3-one, having serine protease inhibiting activity, and particularly excellent inhibiting activity against blood-coagulation factor VIIa
10/05/2010US7807394 Nitro-imidazole hypoxia imaging agents
10/05/2010CA2440839C Sulfoxides or sulfones grafted onto polymers
09/2010
09/30/2010WO2010008831A3 Compounds and methods for modulating g protein-coupled receptors
09/30/2010US20100249424 Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
09/30/2010US20100249367 Benzotriazole containing donor-acceptor type polymer as a multi-purpose material
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100244674 Triazole Derivative, and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using Triazole Derivative
09/30/2010US20100243959 Derivative With Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, Lighting Device, and Electronic Device Using Derivative With Heteroaromatic Ring
09/29/2010EP1399402B1 Intermediate halophenyl derivatives and their use in a process for preparing azole derivatives
09/29/2010CN101228137B Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
09/28/2010US7803822 thrombin receptor antagonists such as N-cyclopropyl-1-{4-[(ethylamino)carbonyl]phenyl}-5-propyl-1H-1,2,3-triazole-4-carboxamide, useful for the treatment of thrombosis, restenosis, necrosis, cardiovascular disorders, disseminated intravascular coagulation syndrome, nervous system disorders and tumors
09/28/2010US7803820 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane
09/28/2010US7803359 UV-absorbers for ophthalmic lens materials
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/28/2010CA2308201C Use of anti-fungal agents for the treatment of fungus-induced mucositis
09/23/2010WO2010105770A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010WO2010105750A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
09/23/2010WO2010087419A3 Cyclopropanecarboxylic acid ester derivatives and their use as pest control agents
09/23/2010US20100240905 Novel Curcumin and Tetrahydrocurcumin Derivatives
09/23/2010US20100240715 Apoptosis promoters
09/23/2010US20100240713 Aromatic and heteroaromatic compounds useful in treating iron disorders
09/23/2010US20100240657 Chemical compounds
09/23/2010DE102010001064A1 Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung Substituted 2-acetamido-5-aryl-1,2,4-triazolones and their use
09/23/2010DE102009013642A1 Substituierte Phenylalaninderivate und deren Verwendung Substituted phenylalanine derivatives and the use thereof
09/23/2010CA2755641A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof
09/23/2010CA2755590A1 Triazole derivatives as vasopressin-receptor inhibitors for treating cardiac insufficiency
09/22/2010EP2230234A1 Process for the preparation of rufinamide
09/22/2010EP2229373A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
09/22/2010EP1853565B1 Menthane carboxamide derivatives having cooling properties
1 ... 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 ... 178